TriSalus (TLSI) director and LLC add 610K shares in open-market buys
Rhea-AI Filing Summary
TriSalus Life Sciences director Michael P. Stansky reported significant open-market buying of the company’s common stock. On May 15, 2026, an entity he manages, Skyview Investments LLC, purchased 200,000 shares at a weighted average price of $2.50 per share, bringing its holdings to 399,698 shares held indirectly. On the same date, he also purchased 410,000 shares directly at a weighted average price of $2.50 per share, increasing his direct ownership to 1,240,722 shares. The filing notes that each block was acquired through multiple trades within stated price ranges.
Positive
- None.
Negative
- None.
Insights
Director and affiliated LLC together bought 610,000 TriSalus shares in open-market transactions.
Director Michael P. Stansky and an affiliated entity, Skyview Investments LLC, executed two open-market purchases of TriSalus Life Sciences common stock on May 15, 2026. Skyview acquired 200,000 shares and Stansky directly acquired 410,000 shares, both at weighted average prices of $2.50 per share.
Following these transactions, Skyview held 399,698 indirect shares and Stansky held 1,240,722 direct shares. The price footnotes show actual trades occurred in ranges of $2.47–$2.55 and $2.46–$2.52, respectively. These are straightforward equity purchases with no derivatives or tax-withholding mechanics disclosed in this filing.
The net result is a net-buy of 610,000 shares with no accompanying sales or derivative exercises reported. Future company filings may provide additional context on how these larger ownership positions evolve over time.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 410,000 | $2.50 | $1.02M |
| Purchase | Common Stock | 200,000 | $2.50 | $500K |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member.
Key Figures
Key Terms
open-market purchase financial
weighted average price financial
indirect ownership financial
voting and dispositive power financial
FAQ
What insider transactions did TriSalus (TLSI) report for Michael P. Stansky?
TriSalus reported that director Michael P. Stansky and an affiliated LLC made two open-market purchases on May 15, 2026. They acquired a combined 610,000 shares of common stock at weighted average prices of about $2.50 per share.
What is Skyview Investments LLC’s position in TriSalus (TLSI) after these trades?
After the reported trades, Skyview Investments LLC held 399,698 TriSalus shares indirectly. It bought 200,000 shares on May 15, 2026 at a weighted average price of $2.50, with individual trades between $2.47 and $2.55.
What prices were paid in the recent TriSalus (TLSI) insider purchases?
The filing lists weighted average prices of about $2.50 per share for both purchases. Skyview’s trades occurred between $2.47 and $2.55, while Stansky’s direct trades ranged from $2.46 to $2.52, all for TriSalus common stock.
Were any TriSalus (TLSI) derivatives or option exercises reported in this Form 4?
No. The transactions disclosed are non-derivative open-market purchases of common stock. The derivative section shows no remaining option or warrant positions in this particular filing, and there are no tax-withholding or gift-related entries reported.